Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Dentin dysplasia type II (DD-II) is a rare mild form of dentin dysplasia (DD) characterized by normal tooth roots but abnormal primary dentition.
Features include always present findings: Thistle tube shaped pulp and Dentinogenesis imperfecta limited to primary teeth. 3 total HPO annotations.
DSPP encodes dentin sialophosphoprotein (1,301 aa). DSP may be an important factor in dentinogenesis. Highest expression in Testis (0.0 TPM) and Artery Aorta (0.0 TPM).
Dentin dysplasia type II is associated with mutations in the DSPP gene on chromosome 4.
The DSPP protein participates in DSPP(463-1301):Integrin alphaVbeta1, Positive Regulation of CDH1 Gene Transcription, and Regulation of CDH1 Gene Transcription pathways.
DSPP is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for DSPP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for dentin dysplasia type II has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for dentin dysplasia type II.
112 publications have been identified in PubMed for dentin dysplasia type II. Research spans Basic Science / Preclinical (37%), Epidemiology / Natural History (18%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 37 | 37% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
18 |
18% |
Research summaries | 16 | 16% |
Patient case studies | 16 | 16% |
Testing and diagnosis research | 7 | 7% |
Clinical study results | 4 | 4% |
New treatment approaches | 2 | 2% |
Ricucci D (2026). [PMID: 41865833](https://pubmed.ncbi.nlm.nih.gov/41865833/). *J Endod*. [Basic Science / Preclinical]
Gao Q (2026). [PMID: 42089717](https://pubmed.ncbi.nlm.nih.gov/42089717/). *Oral Health Prev Dent*. [Epidemiology / Natural History]
Washio A (2026). [PMID: 40828604](https://pubmed.ncbi.nlm.nih.gov/40828604/). *J Biomater Sci Polym Ed*. [Basic Science / Preclinical]
Rodríguez-Lozano FJ (2026). [PMID: 41588682](https://pubmed.ncbi.nlm.nih.gov/41588682/). *Microsc Res Tech*. [Basic Science / Preclinical]
Anselmi C (2026). [PMID: 40974742](https://pubmed.ncbi.nlm.nih.gov/40974742/). *Biomaterials*. [Basic Science / Preclinical]
Sattar SSBA (2026). [PMID: 41862689](https://pubmed.ncbi.nlm.nih.gov/41862689/). *Br Dent J*. [Review / Meta-Analysis]
Boontankun A (2026). [PMID: 42124353](https://pubmed.ncbi.nlm.nih.gov/42124353/). *Restor Dent Endod*. [Epidemiology / Natural History]
Caravello G (2026). [PMID: 41819808](https://pubmed.ncbi.nlm.nih.gov/41819808/). *J Med Genet*. [Diagnostic / Biomarker]
Mahabob N (2026). [PMID: 41912461](https://pubmed.ncbi.nlm.nih.gov/41912461/). *Niger J Clin Pract*. [Diagnostic / Biomarker]
Ali A (2026). [PMID: 42136702](https://pubmed.ncbi.nlm.nih.gov/42136702/). *J Clin Exp Dent*. [Review / Meta-Analysis]